A	FDA	C128490	Structured Product Labeling Risk Evaluation and Mitigation Strategies Terminology	C128899	REMS Approval		
C	FDA	C128491	Structured Product Labeling REMS Requirement Terminology	C128504	Enroll in the REMS		
C	FDA	C128492	Structured Product Labeling REMS Protocol Terminology	C128535	Pharmacotherapy Discontinuation		
C	FDA	C107675	Structured Product Labeling Race Terminology	C16352	Black or African American		
C	FDA	C54599	Structured Product Labeling Limitation of Use Terminology	C41332	ADVERSE REACTION		
C	FDA	C54599	Structured Product Labeling Limitation of Use Terminology	C50646	CONTRAINDICATION		
C	FDA	C54599	Structured Product Labeling Limitation of Use Terminology	C54346	DOSE MODIFICATION		
C	FDA	C54599	Structured Product Labeling Limitation of Use Terminology	C54350	SECOND LINE TREATMENT		
C	FDA	C54599	Structured Product Labeling Limitation of Use Terminology	C54351	USE WITH CAUTION		
C	FDA	C54599	Structured Product Labeling Limitation of Use Terminology	C54352	LIMITED OR NO INFORMATION		
C	FDA	C54599	Structured Product Labeling Limitation of Use Terminology	C54708	INTERACTION		
C	FDA	C54599	Structured Product Labeling Limitation of Use Terminology	C60654	CONDITIONAL APPROVAL		
C	FDA	C54599	Structured Product Labeling Limitation of Use Terminology	C60655	DURATION OF USE